Safety and Immunogenicity of V114 in Healthy Adults (V114-019/PNEU-AGE)
Clinical trial NCT03950622 · COMPLETED
Trial details
- NCT number
- NCT03950622
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-13
- Primary completion
- 2020-03-30
- Enrollment
- 1205
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.